Cite
Boosting the apoptotic response of high‐grade serous ovarian cancers with CCNE1 amplification to paclitaxel in vitro by targeting APC/C and the pro‐survival protein MCL‐1.
MLA
Raab, Monika, et al. “Boosting the Apoptotic Response of High‐grade Serous Ovarian Cancers with CCNE1 Amplification to Paclitaxel in Vitro by Targeting APC/C and the Pro‐survival Protein MCL‐1.” International Journal of Cancer, vol. 146, no. 4, Feb. 2020, pp. 1086–98. EBSCOhost, https://doi.org/10.1002/ijc.32559.
APA
Raab, M., Kobayashi, N. F., Becker, S., Kurunci, C. E., Krämer, A., Strebhardt, K., & Sanhaji, M. (2020). Boosting the apoptotic response of high‐grade serous ovarian cancers with CCNE1 amplification to paclitaxel in vitro by targeting APC/C and the pro‐survival protein MCL‐1. International Journal of Cancer, 146(4), 1086–1098. https://doi.org/10.1002/ijc.32559
Chicago
Raab, Monika, Nene F. Kobayashi, Sven Becker, Csacsko, Elisabeth Kurunci, Andrea Krämer, Klaus Strebhardt, and Mourad Sanhaji. 2020. “Boosting the Apoptotic Response of High‐grade Serous Ovarian Cancers with CCNE1 Amplification to Paclitaxel in Vitro by Targeting APC/C and the Pro‐survival Protein MCL‐1.” International Journal of Cancer 146 (4): 1086–98. doi:10.1002/ijc.32559.